Rachel Duke
Acute Care · Richmond, VANPI 1063716033
Payments from drug & device makers
$750,606in general payments, 2019–2025
Across 819 payments — averaging $916.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$747K
- Musculoskeletal Transplant Foundation Inc.$3K
- Galderma Laboratories, L.p.$602
- Revance Therapeutics, Inc.$87
- Biogen$42
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 783 | $747,276 |
| Musculoskeletal Transplant Foundation Inc. | 23 | $2,598 |
| Galderma Laboratories, L.p. | 9 | $602 |
| Revance Therapeutics, Inc. | 2 | $87 |
| Biogen | 2 | $42 |
How this compares
$750,606 in reported general payments places this provider in the 95th percentile of 599 acute care providers in Virginia.
Other acute care in Richmond
- Mica FerlisRichmond$20K
- Jonathan PenderRichmond$13K
- Erin PerlmutterRichmond$13K
- Emily GilbertRichmond$10K
- Linda HazelgrenRichmond$9K
- Stephanie HerndonRichmond$9K
- Christine RobinsonRichmond$8K
- Kelly McAdamsRichmond$7K
- Linda KashiwabaraRichmond$7K
- Renee TierneyRichmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.